Nectar
PrivateLast Round
Series A
Dec 20, 2022
Total Funding Raised
$24.5M
Company Overview
Nectar operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in December 2022.
Nectar is a healthtech company that provides a comprehensive, vertically integrated allergy healthcare platform offering personalized, patient-centric allergy care.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, D2C Brands, Biotechnology, Patient Engagement
Business Model
B2C
Customer Profile
Hardware + Subscription, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nectar Comparables
Compare Nectar with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wyndly | 94% | |
| Curex | 93% | |
| Allermi | 78% |
For institutional investors. Book with your work email.
Nectar Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 20, 2022 | ||||
| Seed | Mar 17, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nectar Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Juxtapose | Series A, Seed |
| Obvious Ventures | Series A, Seed |
| Harmony Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 117% MoM, reaching 61.5K.
- Dec 20, 2022
$17M round led by Harmony Partners.
For institutional investors. Book with your work email.
Nectar Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nectar's valuation, stock price, and market status.
Is Nectar a public or private company?
Nectar is a private company.
What is the current stock price of Nectar?
Nectar is a private company, so its shares have no public market price. Caplight tracks Nectar's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nectar worth (valuation)?
Valuation information for Nectar is not publicly available.
Can I buy Nectar stock?
Nectar shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nectar's last funding round?
Nectar's most recent funding round was Series A on December 20, 2022.
Who are the main investors in Nectar?
Key investors in Nectar include Juxtapose, Obvious Ventures, Harmony Partners.
Will Nectar IPO soon?
No public IPO plans have been announced for Nectar.
How can I track Nectar secondary market activity?
Caplight tracks bids, offers, and trades in Nectar's shares on secondary markets.